Horizon Therapeutics PLC (OQ:HZNP)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HZNP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 21/20 Feb 21/20 Walbert Timothy P Direct Ownership Ordinary Shares S - Open market or private sale -93,864 $35.23
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Performance Restricted Stock Units (PSUs) A - Grant, award or other under Rule 16b-3(d) 13,644  
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,022 $36.06
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 6,819  
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Performance Restricted Stock Units (PSUs) A - Grant, award or other under Rule 16b-3(d) 20,465  
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,074 $36.06
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 10,232  
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Restricted Stock Units (RSU) A - Grant, award or other under Rule 16b-3(d) 20,465  
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -4,534 $36.06
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 10,232  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HZNP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 23rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Performance Restricted Stock Units (PSUs) A - Grant, award or other under Rule 16b-3(d) 13,644  
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,022 $36.06
Feb 21/20 Feb 19/20 Kent Jeff Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 6,819  
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Performance Restricted Stock Units (PSUs) A - Grant, award or other under Rule 16b-3(d) 20,465  
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,074 $36.06
Feb 21/20 Feb 19/20 DesJardin Michael A. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 10,232  
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Restricted Stock Units (RSU) A - Grant, award or other under Rule 16b-3(d) 20,465  
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -4,534 $36.06
Feb 21/20 Feb 19/20 Curtis Geoffrey M. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 10,232  
Feb 21/20 Feb 19/20 Konstantinovsky Irina Direct Ownership Performance Restricted Stock Units (PSUs) A - Grant, award or other under Rule 16b-3(d) 20,465  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HZNP

Competitors

Competitors with Recent Insider Filings
BridgeBio Pharma (OQ:BBIO)
Arvinas (OQ:ARVN)
Sanara Medtech (PK:SMTI)